BioNano Genomics Inc vs Marathon Petroleum Corp — how do they compare? BioNano Genomics Inc trades at $1.15 (market cap $13.48M), while Marathon Petroleum Corp trades at $303.24 (market cap $86.67B). The key difference: Marathon Petroleum Corp is far larger — about 6429.5× BioNano Genomics Inc's market cap, and Marathon Petroleum Corp pays a 1.32% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | MPC | |
|---|---|---|
Market Cap | $13.48M | $86.67B |
Sector | Health | Energy |
52-Week High | $4.92 | $303.40 |
52-Week Low | $1.09 | $158.59 |
Enterprise Value | $16.09M | $118.85B |
Dividend Yield | — | 1.32% |
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →